Skip to content
Home/Companies/Biotech/Pheiron
Pheiron

Pheiron

Biotech·Germany·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Pheiron?

Pheiron is a German Biotech company, currently owned by Ananda Impact Ventures since 2025.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Ananda Impact Ventures
Investor
Ananda Impact Ventures
Ananda Impact Fund IV · 2022 · Impact

Key facts

HQGermany
SectorBiotech
StatusActive
Websitewww.pheiron.com

More from Ananda Impact Fund IV

Other portfolio companies in the same fund.

Jua
Active
AI/MLSwitzerland· 2025
Mycolever
Active
IndustrialsGermany· 2025
Nordic Salt Cycle
Active
ClimateTechDenmark· 2025
Pulsetrain
Active
MobilityGermany· 2025
Decade
Active
ClimateTechGermany· 2024
Differential Bio
Active
IndustrialsGermany· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Pheiron?

Pheiron is currently owned by Ananda Impact Ventures, through Ananda Impact Fund IV, since 2025.

When did Ananda Impact Ventures acquire Pheiron?

Ananda Impact Ventures acquired Pheiron in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue